The effect of formalin pretreatment on nicotine-induced antinociceptive effect: The role of mu-opioid receptor in the hippocampus

Neuroscience

Volumn 154, Issue 2, 2008, Pages 415-423

  Kwon, M S ^a   Seo, Y J ^a   Choi, S M ^a   Lee, J K ^a   Jung, J S ^a   Park, S H ^a   Suh, H W ^a  

^a Hallym University   (South Korea)

Author keywords

acetic acid; acetylcholine receptors; hippocampus; nicotine; opioid receptors

Indexed keywords

ACETIC ACID; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR ANTAGONIST; FORMALDEHYDE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; NICOTINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG POTENTIATION; HIPPOCAMPUS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VISCERAL PAIN; WESTERN BLOTTING; WRITHING TEST;

ACETIC ACID; ANALGESICS; ANIMALS; BLOTTING, WESTERN; BRAIN; COLORING AGENTS; DRUG TOLERANCE; FORMALDEHYDE; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED ICR; NARCOTIC ANTAGONISTS; NERVE TISSUE PROTEINS; NICOTINE; NICOTINIC AGONISTS; OXAZINES; PAIN; PAIN MEASUREMENT; RECEPTORS, NICOTINIC; RECEPTORS, OPIOID, MU;

EID: 46549083020     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2008.03.053     Document Type: Article

References (41)

1. Aceto M.D., Scates S.M., Ji Z., and Bowman E.R. Nicotine's opioid and anti-opioid interactions: proposed role in smoking behavior. Eur J Pharmacol 248 (1993) 333-335
2. Aloisi A.M., Albonetti M.E., Muscettola M., Facchinetti F., Tanganelli C., and Carli G. Effects of formalin-induced pain on ACTH, beta-endorphin, corticosterone and interleukin-6 plasma levels in rats. Neuroendocrinology 62 (1995) 13-18
3. Aloisi A.M., Casamenti F., Scali C., Pepeu G., and Carli G. Effects of novelty, pain and stress on hippocampal extracellular acetylcholine levels in male rats. Brain Res 748 (1997) 219-226
4. Berrendero F., Kieffer B.L., and Maldonado R. Attenuation of nicotine-induced antinociception, rewarding effects, and dependence in mu-opioid receptor knock-out mice. J Neurosci 22 (2002) 10935-10940
5. Bitner R.S., Nikkel A.L., Curzon P., Arneric S.P., Bannon A.W., and Decker M.W. Role of the nucleus raphe magnus in antinociception produced by ABT-594: immediate early gene responses possibly linked to neuronal nicotinic acetylcholine receptors on serotonergic neurons. J Neurosci 18 (1998) 5426-5432
6. Campbell V.C., Taylor R.E., and Tizabi Y. Effects of selective opioid receptor antagonists on alcohol-induced and nicotine-induced antinociception. Alcohol Clin Exp Res 31 (2007) 1435-1440
7. 2+/calmodulin-dependent protein kinase II and phosphorylated extracellular signal-regulated protein in the mouse formalin pain model. Brain Res 1108 (2006) 28-38
8. Cucchiaro G., Chaijale N., and Commons K.G. The dorsal raphe nucleus as a site of action of the antinociceptive and behavioral effects of the alpha4 nicotinic receptor agonist epibatidine. J Pharmacol Exp Ther 313 (2005) 389-394
9. Damaj M.I. The involvement of spinal Ca(2+)/calmodulin-protein kinase II in nicotine-induced antinociception in mice. Eur J Pharmacol 404 (2000) 103-110
10. Decker M.W., Meyer M.D., and Sullivan J.P. The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control. Expert Opin Investig Drugs 10 (2001) 1819-1830
11. Dutar P., Bassant M.H., Senut M.C., and Lamour Y. The septohippocampal pathway: structure and function of a central cholinergic system. Physiol Rev 75 (1995) 393-427
12. Dutar P., Lamour Y., and Jobert A. Activation of identified septo-hippocampal neurons by noxious peripheral stimulation. Brain Res 328 (1985) 15-21
13. Eisenach J.C., Detweiler D.J., Tong C., D'Angelo R., and Hood D.D. Cerebrospinal fluid norepinephrine and acetylcholine concentrations during acute pain. Anesth Analg 82 (1996) 621-626
14. Feldman S., Conforti N., and Weidenfeld J. Limbic pathways and hypothalamic neurotransmitters mediating adrenocortical responses to neural stimuli. Neurosci Biobehav Rev 19 (1995) 235-240
15. Gendron L., Pintar J.E., and Chavkin C. Essential role of mu opioid receptor in the regulation of delta opioid receptor-mediated antihyperalgesia. Neuroscience 150 (2007) 807-817
16. Grau J.W., Illich P.A., Chen P.S., and Meagher M.W. Role of cholinergic systems in pain modulation: I. Impact of scopolamine on environmentally induced hypoalgesia and pain reactivity. Behav Neurosci 105 (1991) 62-81
17. Hama A., and Menzaghi F. Antagonist of nicotinic acetylcholine receptors (nAChR) enhances formalin-induced nociception in rats: tonic role of nAChRs in the control of pain following injury. Brain Res 888 (2001) 102-106
18. Han K.J., Choi S.S., Shim E.J., Seo Y.J., Kwon M.S., Lee J.Y., Lee H.K., and Suh H.W. Formalin pretreatment attenuates tail-flick inhibition induced by beta-endorphin administered intracerebroventricularly or intrathecally in mice. Arch Pharmacol Res 28 (2005) 227-231
19. Houdi A.A., Dasgupta R., and Kindy M.S. Effect of nicotine use and withdrawal on brain preproenkephalin A mRNA. Brain Res 799 (1998) 257-263
20. Hunskaar S., and Hole K. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 30 (1987) 103-114
21. Jordan B.A., and Devi L.A. G-protein-coupled receptor heterodimerization modulates receptor function. Nature 399 (1999) 697-700
22. Khan I.M., Buerkle H., Taylor P., and Yaksh T.L. Nociceptive and antinociceptive responses to intrathecally administered nicotinic agonists. Neuropharmacology 37 (1998) 1515-1525
23. Khanna S., and Sinclair J.G. Noxious stimuli produce prolonged changes in the CA1 region of the rat hippocampus. Pain 39 (1989) 337-343
24. Koster R., and Anderson M. Acetic acid for analgesic screening. BEJ 18 (1959) 412
25. Laursen S.E., and Belknap J.K. Intracerebroventricular injections in mice. Some methodological refinements. J Pharmacol Methods 16 (1986) 355-357
26. Marubio L.M., del Mar Arroyo-Jimenez M., Cordero-Erausquin M., Lena C., Le Novere N., de Kerchove d'Exaerde A., Huchet M., Damaj M.I., and Changeux J.P. Reduced antinociception in mice lacking neuronal nicotinic receptor subunits. Nature 398 (1999) 805-810
27. Millan M.J. Descending control of pain. Prog Neurobiol 66 (2002) 355-474
28. Morinville A., Cahill C.M., Kieffer B., Collier B., and Beaudet A. Mu-opioid receptor knockout prevents changes in delta-opioid receptor trafficking induced by chronic inflammatory pain. Pain 109 (2004) 266-273
29. Noguchi K., Morita Y., Kiyama H., Sato M., Ono K., and Tohyama M. Preproenkephalin gene expression in the rat spinal cord after noxious stimuli. Brain Res 5 (1989) 227-234
30. Quick M.W., and Lester R.A. Desensitization of neuronal nicotinic receptors. J Neurobiol 53 (2002) 457-478
31. Rogers D.T., and Iwamoto E.T. Multiple spinal mediators in parenteral nicotine-induced antinociception. J Pharmacol Exp Ther 267 (1993) 341-349
32. Seo Y.J., Kwon M.S., Choi S.S., Han E.J., Jung J.S., Choi H.W., Park S.H., Jang J.E., and Suh H.W. Characterization of the hypothalamic proopiomelanocortin gene and beta-endorphin expression in the hypothalamic arcuate nucleus of mice elicited by inflammatory pain. Neuroscience 152 (2008) 1054-1066
33. Shim E.J., Seo Y.J., Kwon M.S., Ham Y.O., Choi O.S., Lee J.Y., Choi S.M., and Suh H.W. The intracerebroventricular kainic acid-induced damage affects animal nociceptive behavior. Brain Res Bull 73 (2007) 203-209
34. Sperk G. Kainic acid seizures in the rat. Prog Neurobiol 42 (1994) 1-32
35. Suh H.W., Song D.K., Choi S.R., Chung K.M., and Kim Y.H. Nicotine enhances morphine- and beta-endorphin-induced antinociception at the supraspinal level in the mouse. Neuropeptides 30 (1996) 479-484
36. Tanimoto M., Fukuoka T., Miki K., Tokunaga A., Tashiro C., and Noguchi K. Effects of halothane, ketamine and nitrous oxide on dynorphin mRNA expression in dorsal horn neurons after peripheral tissue injury. Brain Res 811 (1998) 88-95
37. Tjolsen A., Berge O.G., Hunskaar S., Rosland J.H., and Hole K. The formalin test: an evaluation of the method. Pain 51 (1992) 5-17
38. Wewers M.E., Dhatt R.K., Snively T.A., and Tejwani G.A. The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkelphalin levels in rats. Brain Res 822 (1999) 107-113
39. Wheeler-Aceto H., Porreca F., and Cowan A. The rat paw formalin test: comparison of noxious agents. Pain 40 (1990) 229-238
40. Wonnacott S. The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol Sci 11 (1990) 216-219
41. Zarrindast M.R., Pazouki M., and Nassiri-Rad S. Involvement of cholinergic and opioid receptor mechanisms in nicotine-induced antinociception. Pharmacol Toxicol 81 (1997) 209-213